CPRR Chemistry and Immunoassay Analyzer with Reagents

This contract, identified as solicitation W81K0026QA191, is a small business set-aside issued by the Department of Defense through the Medical Readiness Control Office West in JBSA Fort Sam Houston, Texas, for the lease of one Chemistry and Immunoassay Analyzer along with all associated reagents, consumables, and controls to support operations at the Fox Army Health Center in Huntsville, Alabama. The acquisition is structured on a firm fixed price, cost-per-reportable basis with an estimated base period from August 1, 2026, through July 31, 2027, and includes four optional one-year extension periods. The contractor must complete the full transition—installation, system integration with MHS Genesis and the laboratory information system, validation testing, and comprehensive user training—within 60 days of award. All equipment must be delivered FOB destination with transportation costs borne by the contractor, to the specified address at Redstone Arsenal, and must comply with MIL-STD-130 and MIL-STD-129 for unique identification and shipment labeling, with verification using automatic identification technology compliant with Appendix A of MIL-STD-130. The analyzer and associated services require 24/7 technical support with a one-hour maximum callback response, on-site service within 24 hours of need, and mandatory software updates at no additional cost, while the contractor must also provide notification of any manufacturer recalls within 24 hours. The contract includes stringent data privacy and security obligations aligned with the Privacy Act of 1974, OMB Circular A-130, and requirements for Privacy Impact Assessments and Data Sharing Agreements where DHA data is involved, alongside compliance with FAR clauses prohibiting gratuities, subcontractor sales restrictions, and contracting with inverted domestic corporations, with deviations 2026-O0038 applied to several provisions. Invoice submission is required through the Procurement Integrated Enterprise Environment using a 2-n-1 format, supported by receiving reports meeting DFARS Appendix F, and payment is processed through the DoDAAC HT0821. A Contracting Officer’s Representative will monitor performance but has no authority to obligate funds or modify contract terms. The contractor must maintain a Quality Control Plan and comply with the Quality Assurance Surveillance Plan, submitting all inspection records throughout contract performance and into final settlement. An Organizational Conflict of Interest mitigation plan is required and subject to the Contracting Officer’s sole discretion